Medication info
Mikater Plus Tablet 80/12.5 mg

Mikater Plus Tablet 80/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
White-red biconvex film-coated tablet, which may have red spots on the white layer.
Packaging
30 tablets/box [(10 tablets/Alu-Alu)x3], 30 tablets/bottle
Approval status
Active

MFDS item code 201208654 · Approved 2012.11.23 · Insurance code 642904630

Summary

Main use
Treatment of essential hypertension not controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
Adults Take once daily with water, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be adjusted individually for the patient. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg plus hydrochlorothiazide 12.5mg as separate tablets or with the combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance <30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Administer this medicine with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dosage adjustment is necessary.
Child dose
Under 18 years of age: The safety and efficacy of this medicine have not been established.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used in the treatment of essential hypertension and provides additional blood pressure control for patients whose blood pressure is not sufficiently controlled by monotherapy with telmisartan. This helps manage the patient's blood pressure effectively to aid in the prevention of cardiovascular complications.

How to take

Adult dose

Adults Take once daily with water, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be adjusted individually for the patient. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg plus hydrochlorothiazide 12.5mg as separate tablets or with the combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance <30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Administer this medicine with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dosage adjustment is necessary.

Child dose

Under 18 years of age: The safety and efficacy of this medicine have not been established.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can pose a serious risk to the fetus. Patients with allergies to the components of this medication or those with certain liver or kidney diseases should avoid taking it. Elderly patients, those with issues regarding serum potassium levels, and patients with liver or heart diseases should use this medication with caution. Since this medication lowers blood pressure, there may be occurrences of sudden hypotension, dizziness, or faintness, so caution is necessary. The hydrochlorothiazide component may cause electrolyte imbalances, so potassium and sodium levels should be regularly monitored through blood tests. During the use of this medication, one should avoid excessive sun exposure, and any skin abnormalities should be discussed with a doctor immediately. Interactions may occur if taken with other antihypertensives, diuretics, or potassium supplements, so consultation with a physician or pharmacist is advised. Dizziness or drowsiness may occur when driving or operating machinery, so caution is necessary. In case of overdose, symptoms such as hypotension, electrolyte abnormalities, and dehydration may appear, so one should seek appropriate treatment at a medical facility immediately. Safety has not been established for children, so it is recommended not to use it in pediatric patients. This medication should be kept out of reach of children and stored sealed until use.

Side effects

Bronchitis, pharyngitis, sinusitis, hypokalemia, hyperuricemia, hyponatremia, anxiety, depression, insomnia, sleep disorders, dizziness, syncope, paresthesia, visual impairment, blurred vision, vertigo, tachycardia, arrhythmia, hypotension, orthostatic hypotension, dyspnea, respiratory distress, pneumonia, pulmonary edema, diarrhea, dry mouth, distension, abdominal pain, constipation, dyspepsia, vomiting, gastritis, liver dysfunction, hepatic impairment, angioedema, erythema, pruritus, rash, sweating, urticaria, back pain, muscle spasms, myalgia, arthralgia, limb pain, systemic lupus erythematosus, erectile dysfunction, chest pain, influenza-like illness, pain, increased blood uric acid, increased blood creatinine, increased creatine phosphokinase activity, increased liver enzymes, upper respiratory tract infection, urinary tract infection, cystitis, sepsis, anemia, eosinophilia, thrombocytopenia, anaphylactic reaction, hyperkalemia, hypoglycemia, drowsiness, cough, dry mouth, abdominal discomfort, eczema, drug rash, toxic skin rash, bone pain, renal impairment, myasthenia, increased blood creatinine, increased blood uric acid, decreased hemoglobin, sialadenitis, non-melanoma skin cancer, thrombocytopenic purpura, hemolytic anemia, bone marrow failure, leukopenia, agranulocytosis, hypersensitivity, aplastic anemia, decreased appetite, hypomagnesemia, headache, jaundice, cholestasis, photosensitivity reaction, toxic epidermal necrolysis, lupus-like syndrome, systemic lupus erythematosus, acute renal failure, diabetes, acute respiratory distress syndrome, pancreatitis, fever, dizziness, itching, myalgia, feeling of unsteadiness, headache, lip and hand tremors, sensory hypersensitivity, periodontal disease, lip dryness, decreased vision, hypoglycemia, intestinal vascular edema, nausea, gastrointestinal bleeding, esophagitis, fatigue, weight loss, proteinuria

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius. Proper storage will help preserve the effectiveness and safety of the medication.

Appearance and packaging

Appearance

White-red biconvex film-coated tablet, which may have red spots on the white layer.

Package unit

30 tablets/box [(10 tablets/Alu-Alu)x3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.